Table 1 Baseline characteristics of the patients of the treat-to-target (T2T) and usual care (UC) groups
T2T (n=261) | UC (n=213) | UC from 2006 (n=69) | |
|---|---|---|---|
Age, mean ± SD years | 57.9 ± 13.8 | 56.6 ±13.4 | 53.9 ±13.0† |
Female sex, n (%) | 161 (61.7) | 132 (62.0) | 43 (62.3) |
RF positive, n (%) | 178 (68.2) | 147/211 (69.7) | 48/69 (69.6) |
DAS28, mean ± SD | 5.0 ± 1.1 | 4.8 ± 1.2† | 4.8 ± 1.3 |
No. of swollen joints (28 assessed), median (IQR) | 8 (5–12) | 9 (6–13)† | 8 (5–12) |
No. of tender joints (28 assessed), median (IQR) | 5 (2–9) | 4 (2–9) | 4 (1–9) |
ESR, median (IQR) mm/hour | 28.0 (15.5-42.0) | 26.0 (12.0-39.0) | 29.0 (17.0-43.5) |
CRP, median (IQR) mg/litre | 14.0 (5.0-34.5) | 6.7 (0.0-27.8)† | 10.0 (0.0-34.3) |
VAS general health, mean ± SD (0–100) | 52.9 ± 22.6 | 45.7 ± 23.0† | 42.9 ± 24.4† |
VAS pain, mean ± SD (0–100) | 51.2 ± 21.9 | 44.9 ± 23.2† | 46.5 ± 23.9 |
HAQ score, median (IQR) | 1.1 (0.6-1.5) (n=244) | 0.9 (0.5-1.4) (n=151)† | 0.9 (0.4-1.4) (n=52)† |